HomeSRT3 • FRA
add
Sartorius AG Preference Shares
Nakaraang pagsara
€192.90
Sakop ng araw
€191.30 - €195.80
Sakop ng taon
€169.45 - €291.60
Market cap
13.36B EUR
Average na Volume
254.00
P/E ratio
129.06
Dividend yield
0.37%
Mga balita tungkol sa merkado
Reuters
6 oras ang nakalipas
S&P 500, Nasdaq hit new highs on corporate earnings, Fed meeting in focus
0.30%
0.73%
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 884.30M | 2.74% |
Gastos sa pagpapatakbo | 284.30M | 0.82% |
Net na kita | 32.50M | 35.42% |
Net profit margin | 3.68 | 31.90% |
Kita sa bawat share | 1.22 | 7.02% |
EBITDA | 234.40M | 13.51% |
Aktuwal na % ng binabayarang buwis | 26.94% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 819.00M | 30.96% |
Kabuuang asset | 10.03B | 0.85% |
Kabuuang sagutin | 6.23B | 1.64% |
Kabuuang equity | 3.79B | — |
Natitirang share | — | — |
Presyo para makapag-book | — | — |
Return on assets | 3.27% | — |
Return on capital | 3.90% | — |
Cash Flow
Net change in cash
| (EUR) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 32.50M | 35.42% |
Cash mula sa mga operasyon | 150.20M | -50.17% |
Cash mula sa pag-invest | -89.50M | 13.61% |
Cash mula sa financing | -77.90M | 89.01% |
Net change in cash | -20.60M | 95.97% |
Malayang cash flow | -23.64M | -124.83% |
Tungkol
Sartorius AG is an international pharmaceutical and laboratory equipment supplier. In September 2021, Sartorius was admitted to the DAX, Germany's largest stock market index. Sartorius supports its customers in the development and production of biotech drugs and vaccines. The company has two major divisions: Bioprocess Solutions and Lab Products & Services. Wikipedia
Itinatag
1870
Website
Mga Empleyado
13,685
